EMERYVILLE, Calif. - Kyverna Therapeutics Inc. (NASDAQ: KYTX), a clinical-stage biopharmaceutical company with a market capitalization of $144 million, today announced the appointment of Dr. Naji ...

Oppenheimer reiterated its Outperform rating on Dyne Therapeutics (NASDAQ:DYN), maintaining a $60.00 price target, ...

One-day rouble/dollar futures, which trade on MOEX and are a guide for the over-the-counter exchange rate, were down 0.4% at ...

A beginner's guide to altcoins: discover the diverse world of cryptocurrencies beyond Bitcoin and their risks and potential.